These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17120785)

  • 1. Physicochemical characterization of photopolymerizable PLGA blends.
    Baroli B
    Adv Exp Med Biol; 2006; 585():183-96. PubMed ID: 17120785
    [No Abstract]   [Full Text] [Related]  

  • 2. Ketoprofen-poly(D,L-lactic-co-glycolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics.
    Gabor F; Ertl B; Wirth M; Mallinger R
    J Microencapsul; 1999; 16(1):1-12. PubMed ID: 9972498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The production of uniformly sized polymer microspheres.
    Amsden B
    Pharm Res; 1999 Jul; 16(7):1140-3. PubMed ID: 10450945
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers: Part III. Drug delivery application.
    Wu XS
    Artif Cells Blood Substit Immobil Biotechnol; 2004; 32(4):575-91. PubMed ID: 15974184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres.
    Sinha VR; Trehan A
    Drug Deliv; 2005; 12(3):133-9. PubMed ID: 16025842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and surface modification of polylactide-based polymeric scaffolds for soft-tissue engineering.
    Cao Y; Croll TI; Cooper-White JJ; O'Connor AJ; Stevens GW
    Methods Mol Biol; 2004; 238():87-112. PubMed ID: 14970441
    [No Abstract]   [Full Text] [Related]  

  • 7. Controlled release from coated polymer microparticles embedded in tissue-engineered scaffolds.
    Hu Y; Hollinger JO; Marra KG
    J Drug Target; 2001; 9(6):431-8. PubMed ID: 11822815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein instability in poly(lactic-co-glycolic acid) microparticles.
    van de Weert M; Hennink WE; Jiskoot W
    Pharm Res; 2000 Oct; 17(10):1159-67. PubMed ID: 11145219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Size-dependency of DL-lactide/glycolide copolymer particulates for intra-articular delivery system on phagocytosis in rat synovium.
    Horisawa E; Kubota K; Tuboi I; Sato K; Yamamoto H; Takeuchi H; Kawashima Y
    Pharm Res; 2002 Feb; 19(2):132-9. PubMed ID: 11883639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
    Jackson JK; Hung T; Letchford K; Burt HM
    Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlling degradation of acid-hydrolyzable pluronic hydrogels by physical entrapment of poly(lactic acid-co-glycolic acid) microspheres.
    Lee JB; Chun KW; Yoon JJ; Park TG
    Macromol Biosci; 2004 Oct; 4(10):957-62. PubMed ID: 15487026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new delivery system for antisense therapy: PLGA microspheres encapsulating oligonucleotide/polyethyleneimine solid complexes.
    De Rosa G; Bochot A; Quaglia F; Besnard M; Fattal E
    Int J Pharm; 2003 Mar; 254(1):89-93. PubMed ID: 12615416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems.
    Schwendeman SP
    Crit Rev Ther Drug Carrier Syst; 2002; 19(1):73-98. PubMed ID: 12046892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(lactic-co-glycolic acid) microspheres as an injectable scaffold for cartilage tissue engineering.
    Kang SW; Jeon O; Kim BS
    Tissue Eng; 2005; 11(3-4):438-47. PubMed ID: 15869422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitin/PLGA blend microspheres as a biodegradable drug delivery system: a new delivery system for protein.
    Mi FL; Shyu SS; Lin YM; Wu YB; Peng CK; Tsai YH
    Biomaterials; 2003 Dec; 24(27):5023-36. PubMed ID: 14559016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of various types of scaffold for tissue engineered intervertebral disc.
    Kim SH; Yoon SJ; Choi B; Ha HJ; Rhee JM; Kim MS; Yang YS; Lee HB; Khang G
    Adv Exp Med Biol; 2006; 585():167-81. PubMed ID: 17120784
    [No Abstract]   [Full Text] [Related]  

  • 17. Altered responses of chondrocytes to nanophase PLGA/nanophase titania composites.
    Savaiano JK; Webster TJ
    Biomaterials; 2004; 25(7-8):1205-13. PubMed ID: 14643594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tricaprin on the physical characteristics and in vitro release of etoposide from PLGA microspheres.
    Schaefer MJ; Singh J
    Biomaterials; 2002 Aug; 23(16):3465-71. PubMed ID: 12099290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of tetanus toxoid from adjuvants and PLGA microspheres: how experimental set-up and surface adsorption fool the pattern.
    Johansen P; Corradin G; Merkle HP; Gander B
    J Control Release; 1998 Dec; 56(1-3):209-17. PubMed ID: 9801444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Less harmful acidic degradation of poly(lacticco-glycolic acid) bone tissue engineering scaffolds through titania nanoparticle addition.
    Liu H; Slamovich EB; Webster TJ
    Int J Nanomedicine; 2006; 1(4):541-5. PubMed ID: 17722285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.